Renal impairment in chronic cigarette smokers

J Am Soc Nephrol. 1998 Apr;9(4):562-7. doi: 10.1681/ASN.V94562.

Abstract

To determine the effect of chronic cigarette smoking on renal function, a cross-sectional study was carried out with 30 subjects who had no known vascular disease risk factor other than cigarette smoking, and 24 age- and sex-matched controls without any vascular risk factor including cigarette smoking. Renal function by radionuclide studies of renal plasma flow, GFR, and plasma endothelin-1 concentration was determined. Compared with nonsmokers, smokers had a renal function impairment characterized by a normal GFR and a significant reduction in renal plasma flow as reflected by MAG3 clearance (199.20 +/- 58.85 ml/min per 1.73 m2 versus 256.54 +/- 60.14 ml/min per 1.73 m2; t = 3.52, P < 0.001). MAG3 clearance was significantly correlated with age and smoking. The renal dysfunction was associated with an increase in plasma endothelin-1 concentration (21.56 +/- 1.15 pmol/L versus 25.01 +/- 3.21 pmol/L; t = 5.00, P < 0.001). Former smokers as well had similar, although milder, abnormalities. In conclusion, cigarette smokers manifest an impairment of renal function, suggesting that smoke may have a detrimental effect on renal function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / pharmacokinetics
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / physiopathology
  • Case-Control Studies
  • Cross-Sectional Studies
  • Endothelin-1 / analysis*
  • Female
  • Glomerular Filtration Rate*
  • Glycine / analogs & derivatives
  • Glycine / pharmacokinetics
  • Humans
  • Incidence
  • Kidney Diseases / epidemiology
  • Kidney Diseases / etiology*
  • Kidney Diseases / physiopathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Peripheral Vascular Diseases / epidemiology
  • Peripheral Vascular Diseases / etiology
  • Peripheral Vascular Diseases / physiopathology
  • Regression Analysis
  • Renal Circulation*
  • Risk Factors
  • Smoking / adverse effects*
  • Time Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Endothelin-1
  • N-(mercaptoacetyl)glycine
  • Glycine